The fifth “Asian Healthcare Summit” hosted by the Government of the Hong Kong Special Administrative Region of the People’s Republic of China and the Hong Kong Trade Development Council was held at the Hong Kong Convention and Exhibition Center from May 26 to 27. As an annual event in the healthcare industry, this year’s Asian Healthcare Summit is themed “Global Collaboration, Creating a Better Future”. Experts, investors, and innovators from the global healthcare industry exchanged insights and jointly explored cooperation opportunities in the healthcare field.
At the exhibition, Eieling Technology displayed its core product, the portable liver biosensor Liverscan®, and its blockbuster new product FattaLab®, and discussed innovation and cooperation opportunities in the healthcare industry with experts and scholars.
Innovative technologies enable precise management of chronic liver disease
Liverscan®, the core product of Eieling Technology, has the world’s exclusive patented technology for real-time B-mode ultrasound-guided transient elastography. By collecting position B-ultrasound images and guiding the positioning with real-time image guidance, it can complete the measurement of liver stiffness and acoustic attenuation parameters in 1 minute. This breakthrough technology can help patients to detect the health of their liver in a timely manner and provide a key basis for doctors to formulate personalized chronic liver disease management plans.
In addition, FattaLab®, a new liver fat meter from Eieling Technology, has attracted the favor and interest of many customers. At present, the country pays more and more attention to weight management, and the accurate detection of fatty liver data, as one of the key indicators reflecting the effectiveness of weight management, is of great significance. FattaLab® can complete the data collection of the liver in just 30 seconds, and issue reports instantly through the mobile terminal APP, which greatly improves the efficiency of patients in the process of dynamic monitoring and follow-up visits, provides a strong guarantee for patients to carry out liver health management in a timely manner, and shows great application value in the field of medical health.
Deepen exchanges and cooperation to explore the new future of liver health testing
Eieling Technology also actively conducted in-depth exchanges and cooperation with peers, customers and partners participating in the exhibition. The company team had face-to-face communication with many corporate representatives and scientific researchers from home and abroad, shared the company’s R&D experience and technological achievements, and jointly discussed the trends and opportunities of industry development.
Through this exhibition, Eieling Technology not only met many potential partners but also reached preliminary cooperation intentions with some customers. These collaborations will bring new opportunities and impetus to the company’s product research and development, market expansion, and further promote the company’s development and growth in the field of medical technology. Looking to the future, Eieling Technology will continue to uphold the concept of “original research and innovation”, increase R&D investment, and continue to launch more innovative and competitive products to press the “accelerator” for liver disease prevention and treatment.